These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18854981)

  • 41. [Comparison of perfluorooctane sulfonate and perfluorooctane acid in serum of non-occupational human from Shenyang and Chongqing areas].
    Jin YH; Dong GH; Shu WQ; Ding M; Zhai C; Wang L; Liu X; Saitou N; Sasaki K
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):560-3. PubMed ID: 17086703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noncovalent interactions of long-chain perfluoroalkyl acids with serum albumin.
    Bischel HN; Macmanus-Spencer LA; Luthy RG
    Environ Sci Technol; 2010 Jul; 44(13):5263-9. PubMed ID: 20540534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities.
    Nakayama S; Harada K; Inoue K; Sasaki K; Seery B; Saito N; Koizumi A
    Environ Sci; 2005; 12(6):293-313. PubMed ID: 16609670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New approach for assessing human perfluoroalkyl exposure via hair.
    Alves A; Jacobs G; Vanermen G; Covaci A; Voorspoels S
    Talanta; 2015 Nov; 144():574-83. PubMed ID: 26452864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of perfluorooctane sulfonate on the conformation and activity of bovine serum albumin.
    Wang Y; Zhang H; Kang Y; Cao J
    J Photochem Photobiol B; 2016 Jun; 159():66-73. PubMed ID: 27031195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a fluorescence model for the binding of medium- to long-chain perfluoroalkyl acids to human serum albumin through a mechanistic evaluation of spectroscopic evidence.
    Hebert PC; MacManus-Spencer LA
    Anal Chem; 2010 Aug; 82(15):6463-71. PubMed ID: 20590160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study on the interaction of levocetirizine dihydrochloride with human serum albumin by molecular spectroscopy.
    Liu X; Du Y; Sun W; Kou J; Yu B
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1189-96. PubMed ID: 19857990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Serum Albumin Aggregation/Fibrillation and its Abilities to Drugs Binding.
    Maciążek-Jurczyk M; Janas K; Pożycka J; Szkudlarek A; Rogóż W; Owczarzy A; Kulig K
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
    Wanwimolruk S; Birkett DJ
    Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elucidation of specific binding sites and extraction of toxic Gen X from HSA employing cyclodextrin.
    Perera NLD; Miksovska J; O'Shea KE
    J Hazard Mater; 2022 Mar; 425():127765. PubMed ID: 34838360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of Perfluorooctanesulfonate and 6:2 Chlorinated Polyfluorinated Ether Sulfonate with Human Serum Albumin: A Comparative Study.
    Sheng N; Wang J; Guo Y; Wang J; Dai J
    Chem Res Toxicol; 2020 Jun; 33(6):1478-1486. PubMed ID: 32423201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Albumin binding sites for etodolac enantiomers.
    Mignot I; Presle N; Lapicque F; Monot C; Dropsy R; Netter P
    Chirality; 1996; 8(3):271-80. PubMed ID: 8777148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Cyclodextrin Reverses Binding of Perfluorooctanoic Acid to Human Serum Albumin.
    Weiss-Errico MJ; Miksovska J; O'Shea KE
    Chem Res Toxicol; 2018 Apr; 31(4):277-284. PubMed ID: 29589912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of protein binding of troglitazone stereoisomers by fluorometric titration.
    Izumi T; Hoshiyama K; Enomoto S; Sasahara K; Sugiyama Y
    Biopharm Drug Dispos; 1997 Apr; 18(3):241-57. PubMed ID: 9113346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein.
    Sheng N; Li J; Liu H; Zhang A; Dai J
    Arch Toxicol; 2016 Jan; 90(1):217-27. PubMed ID: 25370009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of perfluorooctanoic acid to rat liver-form and kidney-form alpha2u-globulins.
    Han X; Hinderliter PM; Snow TA; Jepson GW
    Drug Chem Toxicol; 2004 Nov; 27(4):341-60. PubMed ID: 15573471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds.
    Moro G; Liberi S; Vascon F; Linciano S; De Felice S; Fasolato S; Foresta C; De Toni L; Di Nisio A; Cendron L; Angelini A
    Chem Res Toxicol; 2022 Nov; 35(11):2049-2058. PubMed ID: 36148994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel binding site for bile acids on human serum albumin.
    Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
    Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural features of the hydroxy- and keto-disubstituted bile salts: human serum albumin binding.
    Farruggia B; Garcia F; Picó G
    Biochim Biophys Acta; 1995 Sep; 1252(1):59-68. PubMed ID: 7548167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin.
    Dengler TJ; Robertz-Vaupel GM; Dengler HJ
    Eur J Clin Pharmacol; 1992; 43(5):491-9. PubMed ID: 1282889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.